mDR Limited Announces Significant Activity in Quoted Securities

Key Highlights for Investors

• The Group acquired quoted securities worth approximately S\$6.34 million between 27 May 2026 and 5 June 2026.
• This acquisition represents 4.6% of the Group’s latest audited net tangible assets.
• The Group also sold quoted securities valued at approximately S\$149,817 (historical cost) during the same period, representing 0.1% of net tangible assets.
• Following these transactions, the aggregate cost of the Group’s quoted investments increased from S\$354,183,000 to S\$354,968,000.
• The aggregate cost of quoted investments is now 255.1% of the Group’s net tangible assets as of 31 December 2025, up from 254.6% prior to the latest acquisitions.
• The total market value of quoted investments increased slightly from S\$246,223,000 to S\$247,130,000.
• No provision for diminution in value has been made for these investments.
• The Group’s latest audited consolidated net tangible assets as at 31 December 2025 is S\$139,142,000.

Important Shareholder Considerations

• Significant Exposure to Quoted Securities: The Group’s aggregate cost of quoted investments is more than double its net tangible assets, indicating a high exposure to market risk.
• Potential Price Sensitivity: The substantial acquisition of quoted securities (S\$6.34 million) within a short period may signal an aggressive investment strategy, which could affect the Group’s financial stability and share price if the market value of these investments fluctuates.
• No Provision for Diminution: The absence of any provision for diminution in value suggests that the Group currently expects no impairment. However, this could change if market conditions deteriorate.
• Liquidity and Risk Implications: Investors should be aware that the Group’s quoted investments are highly significant relative to its tangible asset base, potentially impacting liquidity and risk profiles.
• Regulatory Disclosure: The announcement was made in accordance with SGX Mainboard Rules 704(17)(b) and 704(18)(b), emphasizing the materiality of these transactions.

Detailed Financial Summary

Potential Share Price Impact

The scale of these acquisitions and the Group’s high concentration in quoted securities could lead to increased volatility in share price, especially if market conditions change or if there is a revaluation of these investments. Investors should closely monitor future updates regarding the performance and valuation of these securities.

Disclaimer

This article is provided for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with professional advisors before making investment decisions. The author and publisher make no representations or warranties regarding the accuracy or completeness of the information contained herein.

新加坡mDR有限公司公告 – 上市证券重大变动

投资者重点信息

• 集团于2026年5月27日至6月5日期间收购了价值约634.3万新元的上市证券。
• 此次收购相当于集团最新审计净有形资产的4.6%。
• 集团同期出售了历史成本约149,817新元的上市证券，占净有形资产的0.1%。
• 交易后，集团上市证券总成本由354,183,000新元增至354,968,000新元。
• 上市证券总成本占集团净有形资产比例由254.6%上升至255.1%。
• 上市证券总市值由246,223,000新元增至247,130,000新元。
• 集团未计提上市证券价值减损准备。
• 截至2025年12月31日，集团最新审计净有形资产为139,142,000新元。

股东重要关注事项

• 高风险敞口：集团上市证券总成本远超净有形资产，显示出较高的市场风险敞口。
• 价格敏感性：短期内大额收购上市证券（634.3万新元）或表明集团采取积极投资策略，若市场波动将直接影响集团财务稳定性及股价。
• 无减值准备：未计提减值准备，说明集团当前对证券价值持乐观态度，但若市场环境恶化，或需重新评估。
• 流动性与风险：投资者需注意集团上市证券占净有形资产比例极高，可能影响集团流动性与风险管理。
• 合规披露：本公告根据新加坡交易所主板规则704(17)(b)及704(18)(b)发布，说明交易具有重大性。

详细财务摘要

股价影响分析

集团对上市证券的高度集中投资，若未来市场变动或证券重新估值，可能导致股价波动加剧。建议投资者持续关注集团后续公告及证券表现。

免责声明

本文仅供参考，不构成投资建议。投资者应自行进行尽职调查并咨询专业意见，作者及发布者不对本文信息的准确性或完整性承担任何责任。

View MDR Limited Historical chart here